Bank of Montreal Can Has $2.40 Million Position in LHC Group (NASDAQ:LHCG)
Bank of Montreal Can reduced its position in shares of LHC Group (NASDAQ:LHCG) by 20.0% during the second quarter, Holdings Channel reports. The institutional investor owned 35,311 shares of the health services provider’s stock after selling 8,829 shares during the period. Bank of Montreal Can’s holdings in LHC Group were worth $2,397,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Invictus RG bought a new position in shares of LHC Group during the first quarter valued at about $125,000. US Bancorp DE raised its position in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares in the last quarter. Mason Street Advisors LLC raised its position in shares of LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock valued at $188,000 after buying an additional 228 shares in the last quarter. Capstone Asset Management Co. bought a new position in shares of LHC Group during the second quarter valued at about $245,000. Finally, Sawgrass Asset Management LLC bought a new position in shares of LHC Group during the first quarter valued at about $241,000. 84.97% of the stock is currently owned by institutional investors.
LHC Group (NASDAQ LHCG) traded up 1.17% on Friday, reaching $63.90. 33,979 shares of the company’s stock traded hands. The company has a market cap of $1.17 billion, a PE ratio of 28.27 and a beta of 0.77. LHC Group has a 12 month low of $32.04 and a 12 month high of $69.35. The firm’s 50 day moving average price is $63.76 and its 200 day moving average price is $56.72.
LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.09. The business had revenue of $260.20 million for the quarter, compared to analysts’ expectations of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. The firm’s revenue for the quarter was up 15.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.52 earnings per share. On average, equities analysts expect that LHC Group will post $2.39 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Bank of Montreal Can Has $2.40 Million Position in LHC Group (NASDAQ:LHCG)” was originally reported by Daily Political and is the property of of Daily Political. If you are reading this piece on another domain, it was illegally stolen and republished in violation of US and international copyright legislation. The original version of this piece can be accessed at https://www.dailypolitical.com/2017/08/11/bank-of-montreal-can-has-2-40-million-position-in-lhc-group-nasdaqlhcg.html.
LHCG has been the topic of several research analyst reports. Zacks Investment Research lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Thursday, July 6th. Oppenheimer Holdings, Inc. reissued an “outperform” rating and set a $68.00 target price (up from $55.00) on shares of LHC Group in a research note on Monday, May 8th. BidaskClub lowered shares of LHC Group from a “buy” rating to a “hold” rating in a research note on Tuesday, July 25th. Royal Bank Of Canada reissued a “buy” rating on shares of LHC Group in a research note on Tuesday, June 13th. Finally, Jefferies Group LLC increased their target price on shares of LHC Group from $56.00 to $65.00 and gave the stock a “buy” rating in a research note on Monday, May 15th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $65.75.
In other news, Director Coliseum Capital Management, L sold 107,463 shares of the business’s stock in a transaction on Tuesday, May 30th. The shares were sold at an average price of $60.63, for a total transaction of $6,515,481.69. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Donald Dwayne Stelly sold 3,181 shares of the business’s stock in a transaction on Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the sale, the chief operating officer now owns 114,235 shares in the company, valued at approximately $7,421,847.95. The disclosure for this sale can be found here. In the last quarter, insiders sold 554,839 shares of company stock worth $34,333,811. 14.80% of the stock is currently owned by company insiders.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.